| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/11/2012 | CN102552211A Preparation composite of agomelatine and preparation method thereof |
| 07/11/2012 | CN102552199A Bulleyaconitine a controlled release tablet |
| 07/11/2012 | CN102552192A Orally disintegrating tablet of sedative-hypnotic medicine and preparation method for same |
| 07/11/2012 | CN102552191A Orally disintegrating tablet of 5-HT receptor agonist and preparation method thereof |
| 07/11/2012 | CN102552188A Agomelatine tablet and preparation method thereof, as well as coated tablet of agomelatine tablet and preparation method thereof |
| 07/11/2012 | CN102552156A Nimodipine freeze-dried solid lipid nanoparticle and preparation method thereof |
| 07/11/2012 | CN102552128A Quetiapine fumarate injection and preparation method thereof |
| 07/11/2012 | CN102552125A Injection composition containing oxiracetam and preparation method and application thereof |
| 07/11/2012 | CN102552107A Two-phase release preparation containing zolpidem or salt of zolpidem and preparation method thereof |
| 07/11/2012 | CN102552105A Cascade brain-targeting drug delivery system as well as preparation method and application thereof |
| 07/11/2012 | CN102551910A Method for establishing rhesus monkey senile dementia model and medicine screening method |
| 07/11/2012 | CN102178746B Medicament for treating cerebral concussion and traumatic injury |
| 07/11/2012 | CN102145128B Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof |
| 07/11/2012 | CN101966199B Application of campanumoea polysaccharide in preparation of medicament and health care food |
| 07/11/2012 | CN101926783B Drug slow control releaser and preparation method thereof |
| 07/11/2012 | CN101905019B Porcine hemagglutinating encephalomyelitis cell culture inactivated vaccine and preparation method thereof |
| 07/11/2012 | CN101829050B Natural brain protein hydrolysate injection and preparation method thereof |
| 07/11/2012 | CN101701218B Immune regulatory oligodeoxynucleotide for inhibiting differentiation of Th1 and Th17 and application thereof |
| 07/11/2012 | CN101646662B Novel prophylactic and/or therapeutic agent for diabetic neuropathy |
| 07/11/2012 | CN101569712B Chinese traditional medicine composition for treating cold |
| 07/11/2012 | CN101522185B Antidepressant agent |
| 07/11/2012 | CN101288641B Coenzyme Q10 water dispersion and preparation method thereof |
| 07/11/2012 | CN101139345B Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/11/2012 | CN101126098B Small disturbance RNA molecule expression carrier for differentially inhibiting GFAP protein expression and its construction method and use thereof |
| 07/11/2012 | CN101006097B Vla-4 antagonists |
| 07/10/2012 | US8217168 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine D3 receptors |
| 07/10/2012 | US8217151 Pasteurisation process for microbial cells and microbial oil |
| 07/10/2012 | US8217146 Neurotrophic factors and methods of use thereof |
| 07/10/2012 | US8217138 Anti-inflammatory compounds and uses thereof |
| 07/10/2012 | US8217028 1,2,4-oxadiazole indole compounds |
| 07/10/2012 | US8217005 Controlled release of phenolic opioids |
| 07/10/2012 | US8217002 Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis |
| 07/10/2012 | US8216995 Relieving pain associated with muscle contractions; treating conditions such as cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretions |
| 07/10/2012 | US8216615 Pawpaw and peach derived composition |
| 07/10/2012 | US8216604 Intranasally administering aqueous solution offentanyl or salt thereof and pectin |
| 07/10/2012 | US8216599 Administering hydroxytyrosol and oleuropein in a ratio of 1:1-200:1 |
| 07/10/2012 | US8216587 Method of vaccination |
| 07/10/2012 | US8216577 Anti-Aβ antibodies and their use |
| 07/10/2012 | CA2632828C Antibodies against amyloid beta with glycosylation in the variable region |
| 07/10/2012 | CA2592995C 1-thio-d-glucitol derivatives |
| 07/10/2012 | CA2566461C Pyrrole compounds as inhibitors of erk protein kinase, synthesis thereof and intermediates thereto |
| 07/10/2012 | CA2542647C Derivatives of n-heterocyclylmethylbenzamides, prepartion method thereof and application of same in therapeutics |
| 07/10/2012 | CA2505195C Quinazolinones as potassium channel modulators |
| 07/10/2012 | CA2494915C Female hormone-containing patch |
| 07/10/2012 | CA2484774C Intracranial treatment of neuropsychiatric disorders by clostridial neurotoxins such as botolinum toxin |
| 07/10/2012 | CA2446951C Polythiourea lipid derivatives |
| 07/10/2012 | CA2437940C Methods of treating diabetes mellitus |
| 07/10/2012 | CA2400916C Aminoadamantane derivatives as therapeutic agents |
| 07/10/2012 | CA2360003C Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 07/10/2012 | CA2305816C Peptides capable of inhibiting the interaction between presenilins and the .beta.-amyloid peptide or its precursor |
| 07/10/2012 | CA2260265C Novel use of phospholipids of animal origin in therapy and/or dietetics |
| 07/10/2012 | CA2211324C Recombinant human alpha-fetoprotein and uses thereof |
| 07/10/2012 | CA2210992C Mixture of fatty acids, derivatives and a compound of vegetal origin having attractive effect on cats |
| 07/10/2012 | CA2194172C Neurturin and related growth factors |
| 07/05/2012 | WO2012092160A2 Human milk oligosaccharides to promote growth of beneficial bacteria |
| 07/05/2012 | WO2012091624A1 Physiologically active bis-dialkylamides of phosphoryl-substituted 1,4-dicarboxylic acids and method for producing same |
| 07/05/2012 | WO2012091571A2 Combination of components for the prevention and treatment of frailty |
| 07/05/2012 | WO2012091549A1 Combination of components for the prevention and treatment of frailty |
| 07/05/2012 | WO2012091542A1 Combination of components for the prevention and treatment of frailty |
| 07/05/2012 | WO2012091449A2 Pharmaceutical composition comprising phosphorylated grasp for treating cystic fibrosis |
| 07/05/2012 | WO2012090713A1 Concomitant drug for improving cognitive function |
| 07/05/2012 | WO2012090676A1 Novel medicinal composition and utilization of same |
| 07/05/2012 | WO2012089828A2 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
| 07/05/2012 | WO2012089738A1 A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease |
| 07/05/2012 | WO2012089607A1 Novel compounds with a 3a-azabicyclo [4.1.0] heptane core acting on orexin receptors |
| 07/05/2012 | WO2012089606A1 Azabicyclo [4.1.0] hept - 4 - yl derivatives as human orexin receptor antagonists |
| 07/05/2012 | WO2012089137A1 Arylurea compound, intermediate and use thereof |
| 07/05/2012 | WO2012088712A1 Compound as wnt signaling inhibitor, composition, and use thereof |
| 07/05/2012 | WO2012065102A3 S-t-butyl protected cysteine di-peptide analogs and related compounds |
| 07/05/2012 | WO2012064836A9 Methods and compositions for neural disease immunotherapy |
| 07/05/2012 | WO2012050921A3 Nd2 peptides and methods of treating neurological disease |
| 07/05/2012 | WO2012049227A3 Novel omega-3 and omega-6 fatty acid compositions and uses thereof |
| 07/05/2012 | WO2012047926A3 Sulfonamide-containing compounds |
| 07/05/2012 | WO2012031220A3 Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use |
| 07/05/2012 | WO2012031028A3 Methods for treating neurodegenerative diseases |
| 07/05/2012 | WO2011162480A9 Composition for treating prion diseases comprising hif-1α agonist |
| 07/05/2012 | WO2011061754A9 A novel 3-substituted 7-imino-2-thioxo-3, 7-dihydro-2h-thiazolo [4,5-di pyrimidin-6-yl - and process for preparation thereof |
| 07/05/2012 | WO2011031816A3 Histamine h3 inverse agonists and antagonists and methods of use thereof |
| 07/05/2012 | US20120172751 Assessment and Modulation of Cerebrospinal Fluid for Head Pain |
| 07/05/2012 | US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/05/2012 | US20120172453 Methods for treating neurodegenerative diseases |
| 07/05/2012 | US20120172431 Omega 3 fatty acid formulations |
| 07/05/2012 | US20120172429 Permanently charged sodium and calcium channel blockers as anti- inflammatory agents |
| 07/05/2012 | US20120172427 (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide tablet formulations with improved stability |
| 07/05/2012 | US20120172426 Compositions, Synthesis, and Methods of Using Cycloalkylmethylamine Derivatives |
| 07/05/2012 | US20120172422 Methods of Treatment Using a Prodrug of an Excitatory Amino Acid |
| 07/05/2012 | US20120172421 2, 6 xylidine derivatives for the treatment of pain |
| 07/05/2012 | US20120172417 System And Method For Identifying And Applying Peripheral Treatment Mechanisms For Disease |
| 07/05/2012 | US20120172409 Methods and kits for linking polymorphic sequences to expanded repeat mutations |
| 07/05/2012 | US20120172402 Induction of alpha helix conformations in proteins and peptides |
| 07/05/2012 | US20120172400 Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 07/05/2012 | US20120172398 Co-crystals of tramadol and coxibs |
| 07/05/2012 | US20120172397 HEXAHYDROCYCLOPENTA[f]INDAZOLE 5-YL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 07/05/2012 | US20120172396 2-adamantylurea derivatives as selective 11b-hsd1 inhibitors |
| 07/05/2012 | US20120172393 (4-Phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone Compounds and Their Use |
| 07/05/2012 | US20120172391 Naphthyridinone analogs as mglur5 positive allosteric modulators |
| 07/05/2012 | US20120172390 Method of treating sleep disorders using the combination of eplivanserin and zolpidem |
| 07/05/2012 | US20120172388 Enhancement of Impaired Motor and Mental Functions, Using Dextromethorphan and Oxidase Enzyme Inhibitor |
| 07/05/2012 | US20120172387 Opioids for the treatment of the restless leg syndrome |
| 07/05/2012 | US20120172382 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities |